Skip to main content
Displaying 161 - 170 of 3940
# Title Department Research Year
161 A novel mesna-based electrochemical sensor embellished with silver nanoparticles for ultrasensitive analysis of modafinil Human Plasma Department of Pharmaceutical Analytical Chemistry 2023
162 A novel microextraction technique aided by air agitation using a natural hydrophobic deep eutectic solvent for the extraction of fluvastatin and empagliflozin from plasma samples: application to pharmacokinetic and drug–drug interaction study† Department of Pharmaceutical Analytical Chemistry 2023
163 A selective dual quenching sensor (EY/BG@CDs) for simultaneous monitoring of gentamicin and ketorolac levels in plasma: a highly efficient platform that caters to the needs of therapeutic drug monitoring† Department of Pharmaceutical Analytical Chemistry 2023
164 Adenine model of chronic renal failure in rats to determine whether MCC950, an NLRP3 inflammasome inhibitor, is a renopreventive Department of Pharmacology 2023
165 An Innovative Polymer-Based Electrochemical Sensor Encrusted with Tb Nanoparticles for the Detection of Favipiravir: A Potential Antiviral Drug for the Treatment of COVID-19 Department of Pharmaceutical Analytical Chemistry 2023
166 Anatase titanium oxide nanoparticles and multi-walled carbon nanotubes-modified carbon paste electrode for simultaneous determination of avanafil and doxorubicin in plasma samples 2023
167 Bifunctional Fe(III) metal-organic framework: A highly sensitive “turn-off” fluorescent probe and a precursor of magnetite nanoparticles for potential water decontamination Department of Pharmaceutical Analytical Chemistry 2023
168 Bifunctional ratiometric sensor based on highly fluorescent nitrogen and sulfur biomass-derived carbon nanodots fabricated from manufactured dairy product as a precursor Department of Pharmaceutical Analytical Chemistry 2023
169 Biosynthesis of polyprenylated xanthones in Hypericum perforatum roots involves 4-prenyltransferase 2023
170 Captopril Polyvinyl Alcohol/Sodium Alginate/Gelatin-Based Oral Dispersible Films (ODFs) with Modified Release and Advanced Oral Bioavailability for the Treatment of Pediatric Hypertension Department of Industrial Pharmacy 2023